TB CARE I
Country of Operation
- Management Sciences for Health (MSH)Not-for-profit
- WHOForeign aid agency or multilateral organization
Target income level
- Bottom 20%
- Lower-middle income (20-40%)
- Middle-income (40-60%)
- Higher middle-income (60-80%)
- High-income (80-100%)
SummaryTB CARE I is a follow-on program to the Tuberculosis Control Assistance Program (TB CAP) and aims to decrease morbidity and mortality by increasing case detection and treatment success of pulmonary TB patients in USAID priority countries.
TB CARE I contribute to three USAID target areas: 1. Sustain or exceed 84% case detection rate and 87% treatment success rate 2. Treat successfully 2.55 million new sputum-positive TB cases 3. Diagnose and treat 57,200 new cases of MDR-TB
Key program components
TB CARE I will focuses on eight priority Technical Areas, namely: Universal and Early Access; Laboratories; Infection Control (IC); Programmatic Management of Drug Resistant TB (PMDT); TB/HIV; Health Systems Strengthening; Monitoring & Evaluation (M&E), Operations Research (OR) and Surveillance; and Drug Supply and Management. There are also four over-arching elements: 1. **C**ollaboration and Coordination 2. **A**ccess to TB services for all people 3. **R**esponsible and Responsive Management Practices 4. **E**vidence-based Monitoring and Evaluation. Within TB CARE I, Management Sciences of Health, the implementing organization, makes unique contributions to strengthening and expanding DOTS programs; improving the capacity and quality of laboratory networks; strengthening TB and HIV/AIDS collaboration; increasing TB data quality and use; and ensuring the sustainable supply of TB drugs. MSH is making significant contributions as a coordinating partner in Afghanistan, Ghana, South Sudan, and several core projects. MSH also plays a key collaborating role in Cambodia, Ethiopia, Indonesia, Kenya, Mozambique, Nigeria, Vietnam, Zambia and other core projects.